Cheng William Hong1, Gavin Hamilton1, Catherine Hooker1, Charlie C Park1, Calvin Andrew Tran1, Jeffrey Schwimmer2, Scott B Reeder3, and Claude B Sirlin1
1Liver Imaging Group, Department of Radiology, University of California, San Diego, San Diego, CA, United States, 2Department of Pediatrics, Division of Pediatric Gastroenterology, Rady Children's Hospital, San Diego, CA, United States, 3Departments of Radiology, Medical Physics, Biomedical Engineering, Medicine, and Emergency Medicine, University of Wisconsin, Madison, Madison, WI, United States
Synopsis
Non-zero
proton density fat fraction (PDFF) is commonly observed in the spleen on
chemical-shift-encoded MRI. A prospective assessment in 42 research subjects with
no visible fat peaks on MR spectroscopy demonstrated small amounts of splenic
fat (PDFF up to 4%) using four different MRI-based fat fraction estimation techniques.
These measurements were poorly correlated with each other, implying that fat
measurements in spleen are likely artifactual rather than representing true
splenic fat.
Introduction
Chemical
shift-encoded (CSE) MRI is an accurate method for the non-invasive in vivo
measurement of proton density fat fraction (PDFF) 1–3. The spleen is known to have no detectable fat
histologically except in exceptionally rare disorders and assumed to have no MR
visible fat. For these reasons, it is sometimes used as a reference standard
for calibration 1. Anecdotally, however, we have observed spleen
CSE-MRI-PDFF values ( > 4%) higher than expected from noise. The purpose of
this study is to describe splenic CSE-MRI-PDFF values in human subjects with
MRS-verified absence of splenic fat. Methods
This was a prospectively designed secondary aim of single-center
clinical trials requiring CSE-MRI and MRS at 3T between April and July 2014. Demographics
were recorded and summarized descriptively. Multi-TR multi-TE MR spectroscopy was
performed with a 2 x 2 x 2 cm3 voxel in the spleen. Spectra were
visually analyzed by an experienced spectroscopist to verify the absence of
splenic fat signal. Patients in whom splenic fat signal could not be excluded
due to contamination by extrahepatic adipose tissue were excluded (Figure 1) 4. Research subjects also
underwent confounder-corrected CSE 3T MRI and had fat quantification in the
spleen using four MRI-based techniques: magnitude-based PDFF (MRI-M), high-signal-to-noise
(SNR) magnitude-based PDFF, complex-data-based PDFF (MRI-C), and high-SNR
complex-data-based PDFF. As PDFF values obtained were right-skewed, the median
and range of PDFF values measured by each technique were reported. Spearman’s
rank correlation coefficient was computed for each pair of measurement
techniques pairwise, and a scatterplot matrix was generated. Results
42
research subjects (17 female, 25 male; median age 14 years old, range 8 – 65; median
BMI 29 kg/m2, range 17 – 41). Median PDFF measured by
magnitude-based PDFF, high-SNR magnitude-based PDFF, complex-data based PDFF, and
high-SNR complex-data based PDFF was, respectively, 2.4% (range: 0.1% - 3.7%), 2.0%
(range: -0.1% – 4.1%), 2.1% (range: 0.4% - 5.8%), and 2.0% (range: 0.3% -
3.5%). Pairwise associations were weak, with the highest rank correlation
coefficient being 0.352 between MRI-M and MRI-C (Table 1). Once correction for
multiple comparisons was performed, none of these associations were
statistically significant. No relationship between PDFF measured by each
technique was observed on the pairwise scatterplot matrix (Figure 2). Discussion
These
results demonstrate that CSE-MRI estimates non-zero PDFF values in human spleen
with MRS-verified absence of MR visible fat.
The poor agreement between PDFF estimated by different CSE-MRI methods
suggest that these values are artifactual rather than representing true fat
signal not observed by MRS. Prior
studies of CSE-MRI-PDFF estimation in human liver have also suggested that PDFF
estimation is noisy in the low-PDFF range, but this is the first study to
evaluate PDFF estimation in an organ that is known to contain no fat and in
which the absence of fat could be verified by MRS. Limitations of this study
include selection bias from analyzing research subjects at a single tertiary
care facility and relatively small sample size. Further technical innovation is
needed to improve the accuracy of CSE-MRI-PDFF estimation in the low-PDFF
range.Conclusion
Advanced
CSE-MRI methods spuriously detect non-zero PDFF values in the human spleen. Acknowledgements
No acknowledgement found.References
1. Reeder SB, Cruite I, Hamilton G, Sirlin CB. Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy. J Magn Reson Imaging 2011;34(4):729–49.
2. Reeder SB, Hu HH, Sirlin CB. Proton density fat-fraction: a standardized MR-based biomarker of tissue fat concentration. J Magn Reson Imaging 2012;36(5):1011–4.
3. Meisamy S, Hines CDG, Hamilton G, et al. Quantification of hepatic steatosis with T1-independent, T2-corrected MR imaging with spectral modeling of fat: blinded comparison with MR spectroscopy. Radiology 2011;258(3):767–75.
4. Hamilton G, Middleton MS, Hooker JC, et al. In vivo breath-hold (1) H MRS simultaneous estimation of liver proton density fat fraction, and T1 and T2 of water and fat, with a multi-TR, multi-TE sequence. J Magn Reson Imaging 2015;42(6):1538–43.